# PROLENSA
> **NDA203168** · New Drug Application · Sponsor: BAUSCH AND LOMB · Approved 2013-04-05
## Drug
- **FDA Application Number:** NDA203168
- **Application type:** New Drug Application
- **Brand name:** PROLENSA
- **Generic name:** BROMFENAC SODIUM
- **Active ingredients:** BROMFENAC SODIUM
- **Dosage form:** SOLUTION/DROPS
- **Route:** OPHTHALMIC
- **Marketing status:** Prescription
- **Sponsor:** BAUSCH AND LOMB
- **Manufacturer:** Bausch & Lomb Americas Inc.
- **First approval:** 2013-04-05
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203168)
---
*AI Analytics · CC0 1.0*